Blog
RSS FeedPosted by Michael Wonder on 02 Nov 2018
Drug Utilisation Sub-Committee outcome statement - September 2018
2 November 2018 - The outcome statement from the September 2018 Drug Utilisation Sub Committee meeting is now available. ...
Posted by Michael Wonder on 28 Oct 2018
PBAC Public Summary Documents - July 2018 meeting
26 October 2018 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2018 PBAC ...
Posted by Michael Wonder on 25 Sep 2018
ICER releases draft evidence report on biologic treatments for asthma
24 September 2018 - Public comment period now open until 22 October 2018; requests to make oral comment during public meeting ...
Posted by Michael Wonder on 31 Aug 2018
Pharma interactions educate and improve health outcomes
31 August 2018 - Medicines Australia is pleased to announce the release of the fifth biannual innovative medicines industry’s transfer ...
Posted by Michael Wonder on 22 Aug 2018
PBAC Drug Utilisation Sub-Committee utilisation analysis - public release documents
22 August 2018 - The utilisation analysis public release documents from the February 2018 DUSC meeting are now available. ...
Posted by Michael Wonder on 17 Aug 2018
Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
17 August 2018 - The PBAC minutes pertaining to the draft review report for the post-market review of the use of ...
Posted by Michael Wonder on 30 Jul 2018
Health system neglects vulnerable Australians: Grattan Institute report
30 July 2018 - Vulnerable Australians are being neglected by a primary health system that is poorly integrated, lacks direction ...
Posted by Michael Wonder on 20 Jul 2018
ICER releases draft evidence report on inotersen and patisiran for hereditary transthyretin amyloidosis
20 July 2018 - Public comment period now open until 17 August; requests to make oral comment during public meeting also ...
Posted by Michael Wonder on 13 Jul 2018
Public Summary Documents – March 2018 PBAC meeting
13 July 2018 - The Public Summary Documents (first time rejections and deferrals) from the March 2018 PBAC meeting are now ...
Posted by Michael Wonder on 12 Jul 2018
ICER releases draft evidence report on anti-androgen therapies for non-metastatic castration-resistant prostate cancer
12 July 2018 - Public comment period now open until 9 August; requests to make oral comment during public meeting also ...
Posted by Michael Wonder on 03 Jul 2018
Centers for Medicare and Medicaid Services Releases Reports on the Performance of the Exchanges and Individual Health Insurance Market
2 July 2018 - Reports show individual market erosion and increasing taxpayer liability. ...
Posted by Michael Wonder on 21 Jun 2018
Script for a healthier Australia: small steps and big savings
20 June 2018 - The latest Australia’s Health report provides persuasive evidence for a concerted national strategy to counter obesity ...
Posted by Michael Wonder on 21 May 2018
Draft report for the post-market review of medicines for pulmonary arterial hypertension
21 May 2018 - The draft report for the post-market review of medicines for pulmonary arterial hypertension is available for public ...
Posted by Michael Wonder on 05 May 2018
ICER releases draft evidence report on elagolix for endometriosis
4 May 2018 - Public comment period now open until 31 May; requests to make oral comment during public meeting also ...
Posted by Michael Wonder on 27 Apr 2018
ICER releases draft condition update report on treatments for plaque psoriasis
27 April 2018 - Public comment period now open until 25 May; requests to make oral comment during public meeting ...